Completed OBSERVATIONAL NCT04418609

Neuro-COVID-19: Neurological Complications of COVID-19 (Neuro-COVID)

Sponsor: Emanuela Keller

Interventions further processing of health data

Updated 7 times since 2020 Last updated: Aug 3, 2022 Started: May 1, 2020 Primary completion: Jun 9, 2022 Completion: Jun 9, 2022

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT04418609, this observational or N/A phase trial focuses on Neurologic Complication and remains completed. Sponsored by Emanuela Keller, it has been updated 7 times since 2020, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

7 versions recorded

Sep 2025 — Present [monthly]

Completed
Sep 2024 — Sep 2025 [monthly]

Completed
Jul 2024 — Sep 2024 [monthly]

Completed
Sep 2022 — Jul 2024 [monthly]

Completed

Status: Recruiting → Completed
Dec 2021 — Sep 2022 [monthly]

Recruiting

▶ Show 2 earlier versions

Jan 2021 — Dec 2021 [monthly]

Recruiting
Jul 2020 — Jan 2021 [monthly]

Recruiting

First recorded

May 2020

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Emanuela Keller

Data source: University of Zurich

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Zurich, Switzerland